Ikarian Capital »

Lenz Therapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Lenz Therapeutics shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.9M 85k 22.33

More positions owned by Ikarian Capital

Krystal Biotech Put Option (KRYS)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Alnylam Pharmaceuticals (ALNY)
Crinetics Pharmaceuticals In (CRNX)
Sarepta Therapeutics (SRPT)
Corcept Therapeutics Incorporated Put Option (CORT)
Tarsus Pharmaceuticals (TARS)
Disc Medicine (IRON)
Soleno Therapeutics (SLNO)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Astrazeneca Sponsored Adr Call Option (AZN)
Bridgebio Pharma (BBIO)
Eyepoint Pharmaceuticals Com New (EYPT)
Biomea Fusion Put Option (BMEA)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
EcoR1 Capital
Samsara BioCapital
Sectoral Asset Management
72 Investment Holdings
Point72 Asset Management
Rtw Investments
Tang Capital Management
BlackRock
Vanguard Group
Alyeska Investment Group
Jennison Associates
Board of Trustees of The Leland Stanford Junior University
Geode Capital Management

View all funds holding Lenz Therapeutics